The overexpression of Prdx6 in ECs prevents AngII-induced inflammation, OS, and endothelial dysfunction via inactivation of the p38 MAPK and c-Jun N-terminal kinase pathways [122]. This evidence concerns the gene PRDX6 and endothelial dysfunction.